Jana Hojcsková
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jana Hojcsková has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Aleš Marek
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czechia
1 shared publication - Michal Kriegelstein
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czechia
1 shared publication - Milos Hroch
Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 14 July 2024
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 67 (9) , 314-323
Direct Multi‐Deuterium Labelling of Pirtobrutinib
Herein, we demonstrate an efficient method for multi‐deuterium labelling of pirtobrutinib—a Bruton's tyrosine kinase inhibitor recently approved by the FDA—using a straightforward hydrogen isotope exchange (HIE) reaction. A remarkably high level of deuterium incorporation was achieved using an excess of a Kerr‐type iridium catalyst. The key factor in the significant deuterium labelling was the decision to employ a deuterium uniformly labelled solvent, chlorobenzene‐d5, at an elevated temperature. Virtually, no d0–d3 species were detected, with only traces of d4–d5 isotopomers (< 5%) observable in the mass spectrum of pirtobrutinib‐d8, fulfilling requirements for stable isotope‐labelled internal standard. The labelled compound—mainly consisting of isotopomers d6–d9 at 82.4% of the total abundance—was isolated in a high yield (73%) and purity (99%). Noteworthy, fluorine group acting as a directing group was observed for the first time. Significant incorporation of deuterium in ortho‐positions, exceeding 87%, was observed. Interestingly, chlorinated solvent used in the HIE reactions was non‐specifically deuterated yielding up to 0.42 deuterium per chlorobenzene molecule even at an exceptionally low iridium catalyst loading of 4.17 × 10–2 mol%.
- 14 July 2024
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 67 (9) , 314-323
Open AccessDirect Multi‐Deuterium Labelling of Pirtobrutinib
Herein, we demonstrate an efficient method for multi‐deuterium labelling of pirtobrutinib—a Bruton's tyrosine kinase inhibitor recently approved by the FDA—using a straightforward hydrogen isotope exchange (HIE) reaction. A remarkably high level of deuterium incorporation was achieved using an excess of a Kerr‐type iridium catalyst. The key factor in the significant deuterium labelling was the decision to employ a deuterium uniformly labelled solvent, chlorobenzene‐d5, at an elevated temperature. Virtually, no d0–d3 species were detected, with only traces of d4–d5 isotopomers (< 5%) observable in the mass spectrum of pirtobrutinib‐d8, fulfilling requirements for stable isotope‐labelled internal standard. The labelled compound—mainly consisting of isotopomers d6–d9 at 82.4% of the total abundance—was isolated in a high yield (73%) and purity (99%). Noteworthy, fluorine group acting as a directing group was observed for the first time. Significant incorporation of deuterium in ortho‐positions, exceeding 87%, was observed. Interestingly, chlorinated solvent used in the HIE reactions was non‐specifically deuterated yielding up to 0.42 deuterium per chlorobenzene molecule even at an exceptionally low iridium catalyst loading of 4.17 × 10–2 mol%.